What was the recent INFU analyst rating change?

On Feb 24, 2026 Roth Capital maintained a **Buy** on InfuSystem (INFU) and raised its price target to **$15**. This is the single rating action recorded for that date and reflects post-earnings confidence.

How should investors interpret the INFU analyst rating?

A maintained Buy with a higher price target indicates analyst confidence in growth and margin trends. It supports a positive view but does not replace due diligence on guidance, cash flow, and execution risk.

Did the INFU analyst rating move the stock price?

The provided entry shows no immediate price change. Rating moves can influence sentiment, but price response depends on volume, market context, and company fundamentals.

What is Meyka AI’s assessment after the INFU analyst rating?

Meyka AI rates **INFU analyst rating** with a stock grade of **B+**, balancing growth guidance, sector peers, and analyst views. This is an informational grade, not investment advice.

Analyst Ratings

Roth Capital Maintains Buy on INFU InfuSystem Holdings, Inc. Feb 24 2026

ByHuzaifa Zahoor February 25, 2026February 25, 2026

Roth Capital on Feb 24, 2026 maintained a Buy on InfuSystem Holdings, Inc. (INFU) and lifted its price target to $15, the latest INFU analyst rating update. This move came after InfuSystem’s Q4 2025 call and management guidance for 6% to 8% revenue growth in 2026. Roth’s decision signals continued analyst confidence in InfuSystem’s service margins and IT efficiency gains. Investors should note the firm’s market cap of $174,687,815 and that this report is the only rating action recorded on the date provided.